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Background
This study is about the application of telepathology in
external quality assurance (EQA) for cervical and breast
cancer screening programmes.
In Veneto Region, Italy, an organized effective mass-
screening programme for cervical and breast cancer has
been active since 1998. The previously experienced EQA
with slide set circulation on a voluntary base by part of
the Anatomic Pathology laboratories of this Region had
failed because of several complications: slide’s circulation
around more than 20 Anatomic Pathology services takes
a great deal of time; there is a high risk of slide loss and/
or break down during the multiple slides’ deliveries;
patients’ privacy and operators’ anonymity can be regret-
tably compromised.
The EQA has recently become a mandatory require-
ment for accreditation of laboratories providing screen-
ing services within Veneto.
The whole image acquisition technology of cytological
and histological slides, thank to innovative software, has
become available in the last few years. These applica-
tions permit pathologists to storage digital images and
to examine, on digital screen, virtual slides scanned in a
far away laboratory, using a viewer downloaded from
internet in an easy and, in most cases, free way.
In 2008 a slide scanner (Aperio ScanScope-XT) was
installed at Anatomic Pathology Laboratory in Rovigo,
Italy. This technical tool, with the proper ICT (Informa-
tion and Communication Technology) configurations
and architecture, became available to the Anatomic
Pathology Units in Veneto.
Such technology is still in early application stage, so
that we evaluate its potential use in EQA for cervical
and breast cancer screening programmes.
Material and methods
In 2008 a committee (one for cervical and one for breast
cancer screening) has been elected among the patholo-
gists involved in Veneto mass-screening programme for
cervical and breast cancer to plan the EQA.
From 2009 to 2011 a year topic has been chosen
among those hot in the field of cytopathology and histo-
pathology of cervical and breast cancer screening.
Every year, in Veneto each laboratory participating in
the project selected from routine files 1 to 3 cervical and
breast cytologic and histologic samples. The selected sam-
ples were mailed to Clinical Pathology Department in
Rovigo, where they have been anonymized and digitalized
by using a ScanScope-XT. The images have been stored
on a virtual slide repository available online for a web con-
sultation. The personalized free access has been made
available on website [1]. The experience with virtual slide
technical tools was very different among the participant
pathologists. No training, focused on virtual pathology,
was given to the participant pathologists before the virtual
slide-based EQA project started. Remote ICT support,
when requested, was available to each participant. The
project manager of each screening group collected the
anonymized diagnoses. Each committee provided a gold
standard diagnosis. The discordant cases have been pro-
posed for plenary discussion in a year meeting, in the
attempt to reach agreement among the participants.
Results
Twenty-three public laboratories out of twenty-four active
in Veneto joined the project. From 2009 to 2011, virtual
slides have been created from 98 cervical smears and from
the 102 corresponding biopsies. Similarly, virtual slides
have been created from 52 breast cancer samples, 48
breast needle core biopsies and 95 breast FNAC. On vir-
tual cervical slides, a total of 1717 cytological diagnoses
and 1719 histopathological diagnoses have been obtained;
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on virtual breast slides, a total of 1717 cytological diag-
noses and 1822 histopathological diagnoses have been
obtained.
In 2009 only 59% of the participant laboratories for cer-
vical EQA and 80% for breast EQA could successfully
evaluate the virtual slides. Most of the participants
couldn’t download and install the viewer or complained
the low performances during slides’ evaluation.
In 2009 some non-sense incoherent diagnoses have been
registered.
In 2011 the virtual slides have been successfully evalu-
ated by all participants.
Discussion
EQA has become an integral part of mass-screening pro-
gramme development in Italy. Ideally, the scheme should
include slide set circulation, but several obstacles prevent
the adequate diffusion of such practice. The EQA based on
circulating slides is still practiced but in only a few “niche”
applications [2]. For this reason, the use of digital slides
would represent a helpful alternative for the EQA [3,4].
The major issues limiting the use of virtual slide-based
EQA in the first years of our EQA project did not involve
image acquisition or quality but rather the pathologist’s
experience with virtual slide technical image management
and several issues such as the pathologist’s interface and
the hospital’s network. The need for standardization of
technical elements of image has already been pointed out
[5,6]. Moreover, very recently these technical standards in
the contest of mass-screening programme have been
established by a preeminent European committee [7].
Several challenges can be pointed for the next few years
to allow the wide and easy application of virtual pathology
in EQA: on one hand there is the need to focus on pathol-
ogist’s training with virtual slide technical tools; on the
other hand, there is the need to improve the hospital’s net-
work, to homogenize the security policies, to adequate the
technical tools of each Anatomic Pathology Unit to the
recently proposed standard [7].
These results are encouraging to purse this workgroup,
able to involve the participants in screening programmes,
with a very good cost/benefit ratio.
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